REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements |
|
for the Year Ended 30 April 2021 |
|
for |
|
Medcraft Holdings Limited |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements |
|
for the Year Ended 30 April 2021 |
|
for |
|
Medcraft Holdings Limited |
Medcraft Holdings Limited (Registered number: 08619277) |
|
Contents of the Financial Statements |
for the Year Ended 30 April 2021 |
|
|
|
|
|
|
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
Notes to the Financial Statements | 3 |
|
Medcraft Holdings Limited |
|
Company Information |
for the Year Ended 30 April 2021 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
Chartered Accountants |
Riverside View |
Basing Road |
Old Basing |
Basingstoke |
Hampshire |
RG24 7AL |
Medcraft Holdings Limited (Registered number: 08619277) |
|
Balance Sheet |
30 April 2021 |
|
30.4.21 | 30.4.20 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Investments | 4 |
|
|
|
CURRENT ASSETS |
Debtors | 5 |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 6 |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CAPITAL AND RESERVES |
Called up share capital | 7 |
|
|
Retained earnings |
|
|
SHAREHOLDERS' FUNDS |
|
|
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
|
The financial statements were approved by the Board of Directors and authorised for issue on
|
|
|
|
|
|
|
|
Medcraft Holdings Limited (Registered number: 08619277) |
|
Notes to the Financial Statements |
for the Year Ended 30 April 2021 |
|
|
1. | STATUTORY INFORMATION |
|
Medcraft Holdings Limited is a
|
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Investments in subsidiaries |
Investments in subsidiary undertakings are recognised at cost. |
|
Financial instruments |
Debtors and creditors payable/receivable within one year |
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. |
|
Loans and borrowings |
Loans and borrowings are initially recognised at the transaction price, including transaction costs. Subsequently they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value. |
|
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, adjusted for indexation where applicable. |
|
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
|
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
|
Impairment |
Assets not measured at fair value are reviewed for any indication that an asset may be impaired at each balance sheet date. The directors review the carrying amount of the relevant assets and compare them to their market values and recoverable amounts. Where the carrying amount exceeds this, an impairment loss is recognised in profit or loss, unless the asset is carried at a revalued amount, where the impairment loss is a revaluation decrease. |
Medcraft Holdings Limited (Registered number: 08619277) |
|
Notes to the Financial Statements - continued |
for the Year Ended 30 April 2021 |
|
|
3. | EMPLOYEES AND DIRECTORS |
|
The average number of employees during the year was
|
|
4. | FIXED ASSET INVESTMENTS |
Shares in |
group |
undertakings |
£ |
COST |
At 1 May 2020 |
and 30 April 2021 |
|
NET BOOK VALUE |
At 30 April 2021 |
|
At 30 April 2020 |
|
|
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.4.21 | 30.4.20 |
£ | £ |
Amounts owed by group undertakings |
|
|
Other debtors |
|
|
|
|
|
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.4.21 | 30.4.20 |
£ | £ |
Taxation and social security |
|
|
Other creditors |
|
|
|
|
|
7. | CALLED UP SHARE CAPITAL |
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 30.4.21 | 30.4.20 |
value: | £ | £ |
|
Ordinary | £1 | 100 | 100 |
|
8. | RELATED PARTY DISCLOSURES |
|
At the balance sheet date £nil (2020: £19,500) was owing from a company related by a common shareholder. |
Medcraft Holdings Limited (Registered number: 08619277) |
|
Notes to the Financial Statements - continued |
for the Year Ended 30 April 2021 |
|
|
9. | SHARE OPTION SCHEME |
|
The company operates a share option plan for selected employees of the group. The options vest on the occurrence of a sale of the company and may be exercised with in the period beginning with the date of sale and ending 30 days thereafter and shall lapse and cease to be exercisable at the end of that period. |
|
If the options remain unexercised after a period of 10 years from the date of grant, the options expire. Options may not be exercised if the employee leaves the group before the options vest except where the Board permits it under certain clauses or the employment terminates for certain reasons. |
|
During the year the company has granted an employee an option to purchase 33 Ordinary shares with an exercise price of £19,000 per share. These options expire in August 2029. |